GleamWall
中文EN

ZOMDF Zomedica Corp.

Pharmaceutical Preparations · OTC · SEC CIK 1684144 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY31.3%
TTM net income YoY81.1%
TTM EPS YoY88.9%
Revenue 3-yr CAGR17.2%
Net income 3-yr CAGR—

Margins

Gross margin64.0%
Operating margin-45.4%
Net margin-41.4%
FCF margin-30.8%
EBITDA margin-40.0%

Returns

ROE-14.3%
ROA-13.0%
ROIC (approx.)-13.3%
Asset turnover0.31x

Leverage & solvency

Liabilities / assets9.3%
Debt / equity0.00x
Current ratio6.09x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.72x
Accruals ratio-3.7%
Payout ratio—
Capex / revenue1.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$32.03M$27.29M
Cost of revenue$10.35M$8.20M
Gross profit$21.68M$19.09M
R&D expense$7.17M$7.27M
SG&A expense$24.50M$29.66M
Operating income-$84.35M-$51.05M
Pretax income-$82.14M-$47.54M
Income tax-$278,000-$557,000
Net income-$81.86M-$46.98M
EBITDA-$82.30M-$49.51M
EPS (basic)-0.08-0.05
EPS (diluted)-0.08-0.05
Weighted avg. shares (diluted)979.95M979.95M
Balance sheet
Cash & equivalents$9.02M$7.02M
Receivables$3.01M$2.42M
Inventory$5.54M$5.06M
Current assets$64.04M$81.77M
PP&E, net$20.91M$24.59M
Goodwill$0$45.56M
Intangibles$38.81M$52.54M
Total assets$127.04M$207.36M
Current liabilities$9.45M$9.33M
Total liabilities$11.64M$11.70M
Shareholders' equity$115.40M$195.66M
Shares outstanding979.95M979.95M
Cash flow statement
Operating cash flow-$17.65M-$23.63M
Capital expenditure$567,000$5.21M
Free cash flow-$18.22M-$28.84M
Investing cash flow$19.57M$17.85M
Financing cash flow—-$70,000
Depreciation & amortization$2.06M$1.54M
Stock-based compensation$2.47M$2.78M

Free plan shows the latest 2 periods; Pro shows all 10 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.